Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

Conventional drug delivery is known for being both a lengthy and expensive process, with pre-clinical testing taking between three to six years and costing between hundreds of millions of dollars to ...

Drug development is a complex and time-consuming endeavor that traditionally relies on the experience of drug developers and trial-and-error experimentation. The ...

Drug discovery focuses on identifying potential therapeutic compounds that can treat different disease conditions. It is a complex process with multiple steps that requires synergy among various ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

We know the scientific method to be sequential and empirical: Ask, observe, hypothesize. Test, analyze, report. And then do it all over again, and again, and again. For better or worse, that sequence ...

Artificial intelligence (AI) can accelerate drug development, reduce costs, and improve treatment efficacy, but faces challenges like data quality and regulatory hurdles. Over 900 FDA-approved ...

Although computational methods within drug discovery are well established, there is an indisputable gap when it comes to novel AI tools capable of rapidly, robustly and cost-effectively predicting the ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is hoping to use AI to streamline this process, it announced Tuesday. Amazon ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

Drug discovery startup Converge Bio Inc. said today it has closed on a $5.5 million seed round of funding to help biotech and pharmaceutical companies develop more effective drugs at faster speeds by ...